Back to Journals » Vascular Health and Risk Management » Volume 20
Global Research Trends on Exosome in Cardiovascular Diseases: A Bibliometric-Based Visual Analysis
Authors Gu Y, Feng J , Shi J, Xiao G, Zhang W, Shao S, Liu B, Guo H
Received 9 May 2024
Accepted for publication 10 August 2024
Published 22 August 2024 Volume 2024:20 Pages 377—402
DOI https://doi.org/10.2147/VHRM.S473520
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Pietro Scicchitano
Yunxiao Gu,* Jiaming Feng,* Jiayi Shi,* Guanyi Xiao,* Weiwei Zhang, Shuijin Shao, Baonian Liu, Haidong Guo
Department of Anatomy, School of Chinese Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Baonian Liu; Haidong Guo, Department of Anatomy, School of Chinese Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China, Email [email protected]; [email protected]
Background: Exosomes in cardiovascular diseases (CVDs) have attracted huge attention with substantial value and potential. Our bibliometrics is based on literature from the field of cardiovascular exosomes over the past 30 years, which has been visualized to display the development process, research hotspots, and cutting-edge trends of clinical practices, mechanisms, and management strategies related to psych cardiology.
Methods: We selected articles and reviews on exosomes in CVDs from the core collection of Web of Science, and generated visual charts by using CiteSpace and VOSviewer software.
Results: Our research included 1613 publications. The number of exosome articles in CVD fluctuates slightly, but overall shows an increasing trend. The main research institutions were Tongji University and Nanjing Medical University. The International Journal of Molecular Sciences has the highest publication volume, while the Journal of Cellular and Molecular Medicine has the highest citation count. Among all the authors, Eduardo Marban ranks first in terms of publication volume and H-index. The most common keywords are exosome, extracellular vesicles, and angiogenesis.
Conclusion: This is a bibliometric study on the research hotspots and trends of exosomes in CVD. Exosome research in the field of cardiovascular medicine is on the rise. Some exosome treatment methods may become the focus of future research.
Keywords: exosomes, cardiovascular diseases, bibliometric, citespace, VOSviewer
Introduction
Exosomes are common membrane-bound nanovesicles containing various biomolecules such as lipids, proteins, and nucleic acids.1,2 They can be secreted by almost all types of cells under physiological and pathological conditions, which contribute to fundamental physiological processes, including neuronal communication,3,4 antigen presentation,5 immune responses,6,7 organ development8–10 and reproductive performances.11 They play a central role in intercellular information exchange, which helps to regulate communication between different cells.12,13 Thus, they are considerable in multicellular systems, such as the heart.14,15
In recent research, exosomes show immense potential in cardiovascular diseases.16,17 For instance, they can prevent the cardiomyocyte apoptosis induced by HSP60 activating Toll-like receptor,18,19 carry miRNA to orchestrate adaptive measures when myocardial infarction happens,20,21 regulate differentiation, proliferation, and survival of cardiac progenitor cells, cardiomyocytes, and fibroblasts,22–25 etc. Marban’s group found that exosomes secreted by CDCs play a key role in cardiac regeneration. Their data showed that exosomes are involved in angiogenesis, survival and proliferation of cardiomyocytes.26
Bibliometrics is an interdisciplinary science, covering mathematics and statistics, and carrying out quantitative analysis of all knowledge carriers which can describe or show relationships between published work.27 This method can quantitatively measure the contour distribution, relationship, and clustering of the research field.28 In order to study the hotspots and development trends of exosome research in CVD in the past 30 years, we used CiteSpace and VOSviewer software, and mapped the scientific knowledge.
Methods
Data Sources and Searches
Literature was extracted from the Web of Science. The search formula was as follows: TS = (“exosomes” OR “exosome” OR “exocrine”) AND TS = (“high blood pressure” or hypertensi* or “peripheral arter*” disease* or “atrial fibrillat*” or tachycardi* or endocardi* or pericard* or ischem* or arrhythmi* or thrombo* or cardio* or cardiac* or “heart failure” or “heart beat” or “heart rate*” or “heart val*” or coronary* or angina* or ventric* or myocard*) AND DT = (Article OR Review) AND LA = (English) AND DOP = (1992–01-01/2023-08-31. The number of articles retrieved was 4479. According to our screening, 2866 unrelated literature were removed, and 1613 remained, including 1132 articles and 481 reviews. Then we carried out the following analysis work: general data, author and co-cited authors, journal and co-cited journal Institution, countries/regions, keywords, and co-cited reference. The detailed filtering process is demonstrated in Figure 1.
![]() |
Figure 1 Flowchart of literature selection. |
Data Analysis
VOSviewer is an important measurement network analysis software, which can visualize the analysis results, including the construction of network maps of academic publications, scientific journals, authors, research institutions, countries and keywords. The projects in these networks are connected by co-citation, co-occurrence, citation and bibliographic coupling. VOSviewer software provides three kinds of visual maps: network, overlay and density visualization.29 It is suitable for large-scale data and can be drawn into graphs.30 CiteSpace software is also an analysis software based on scientific measurement and data visualization.31 Through the data mining, information analysis and Atlas drawing functions of the software, we can understand the structure, law and distribution of scientific knowledge. Knowledge mapping is an important branch of information technology. It can intuitively visualize the research hotspots and evolution process, and predict the development trend of each field, which is often used in Bibliometric research.30,32 We combined CiteSpace and VOSviewer software to visually analyze the distribution of countries/regions, authors and co-cited authors, journals and co-cited journals, co-cited references, keyword clustering analysis, and timelines.
Results
Annual Publication Outputs
The development trend of research in a field can be reflected by the number of papers published in a certain period (Figure 2). According to the figure, from 2001 to 2020, the number of research published on exosomes in CVDs showed a gradually increasing trend. Since the research and development of exosomes in cardiovascular science were infant before 2009, the number of published articles was relatively low. From 2010 to 2021, the number of published articles increased stably and rapidly, and reached its summit in 2021 of over 300 outputs. However, the number ushered in a decline in 2022 and 2023, which may result from the pandemic. Nevertheless, the rapid development of research in this field further confirms its potential value. At the same time, the citation volume of related papers continues to increase almost exponentially (2004–2021), which not only indicates that the field has received widespread attention, but also reflects its huge potential for future development.
![]() |
Figure 2 Trends in the growth of publications worldwide from 2004 to 2023. |
Contribution of Countries/Regions
A total of 1613 articles were published. As shown in Table 1, the most significant number of publications came from China (806, 48.32%) and the US (434, 26.02%), followed by Italy (82, 4.92%), the UK (71, 4.26%), and Germany (55, 3.30%). Wherein, the largest increase in the number of publications came from China, which ranked second with 333 publications in 2021,32 and even nearly half of the total in our statistics. Several countries, such as the US (272), China (158), the UK (112), Germany (96), and Italy (88), showed high total link strength, circled in blue in Figure 3A. This finding indicates that these countries have played an important role in the study of exosomes in CVDs. The thickness of the connection represents the closeness of the cooperation, and the connection between the two countries represents the cooperation between them. The size of a country’s node represents the relative number of documents published in that country. Figure 3 shows 37 nodes and 5 clusters. It can be seen that China has the highest overall number of publications and citations. Although the United States is not the country with the highest number of publications and citations, it collaborates globally. The United States pays more attention to the global perspective and has closer ties with foreign countries.
![]() |
Table 1 Top 10 Countries and Institutions That Contributed to Publications of Exosome in CVD |
Contribution of Institutions
A total of 1613 articles were published. According to Table 1, the most significant number of publications among institutions came from Nanjing Med Univ (52, 15.57%) and Tongji Univ (40, 11.98%), followed by Shanghai Jiao Tong Univ (36, 10.78%), Fudan Univ (34, 10.18%), and Soochow Univ (31, 9.28%). Most of the top 10 institutions came from China, which totally published 305 articles. Several institutions, such as Nanjing Med Univ (51), Tongji Univ (46) and Shanghai Jiao Tong Univ (30) showed high total link strength, colored green in Figure 3B. This finding indicates that these institutions have played an important role in the study of exosomes in CVDs. If the color is close to yellow, it means that the organization has been more active recently, while blue has been more active in the past. The thickness of the connection represents the closeness of the cooperation, and the connection between two countries represents the cooperation between them. The size of an organization’s node represents the relative number of documents issued by the organization. Figure 4 shows 67 nodes and 8 clusters. There is active cooperation among institutions, including Nanjing Med Univ., Tongji Univ., and Capital Med Univ.
![]() |
Figure 4 The relationship of the countries, institutions, and journals produced articles based on an alluvial flow map based on R for exosomes in CVDs. |
Authors and Co-Cited Authors
Table 2 shows the top ten authors in extracellular vesicle research in the field of cardiovascular disease, as well as their number of publications, citations, citations/number of publications, and H-index. Marban Eduardo had the highest number of published papers (22), followed by Barile Lucio (20), Ke Cheng (19), Junbo Ge (16), and Kishore Raj (16). Marban Eduardo also had the highest citation (2206), followed by Sahoo Susmita (1940). Marban Eduardo and Barile Lucio hold the highest H-index (16). Marban Eduardo mainly focuses on heart protection33,34 and reviewing the direction of exosome therapy.35 Barile Lucio researched the identification and characterization of exosomes.36 Each author has a high citation rate, suggesting that their articles have high academic value.
![]() |
Table 2 Top 10 Authors in the Field of Exosome in CVDs |
Table 3 shows the top 10 co-cited authors in the field of exosomes in CVDs. If two or more authors are cited simultaneously, they will create some kind of connection invisibly. The more times they are cited together, the stronger the connection between them, which is co-cited author. The most frequently co-cited authors were Barile, L (502 citations, TLS: 21492), Lai Rc (418 citations, TLS: 16255) and Thery C (417 citations, TLS: 16162).
![]() |
Table 3 Top 10 Co-Cited Authors in the Field of Exosome in CVDs |
Journal and Co-Cited Journals
According to Table 4, It can be seen that the total citations of these journals vary from 22 to 59. Among them, the journal with the highest number of articles is “International Journal of Molecular Sciences”, which has 59 articles. We can observe the citation/ document of each article. This index can reflect the influence and quality of journals. It can be seen from the data that each article in “Journal of Cellular and Molecular Medicine” has been cited 43.13 times on average, which is the most frequently cited of all journals. We can also focus on the total link strength of journals. This index can reflect the citation relationship and network influence between journal articles. It can be seen from the data that the total link strength of “Circulation Research” is the highest, reaching 1057. We can also focus on the impact factor (IF2022) and H-index (H-index) of journals. These two indicators are also important indicators to evaluate the influence of journals. According to the data, the impact factor of “Circulation Research” is the highest, reaching 20.1, while the journal with the highest H-index is “Circulation Research”, reaching 24.
![]() |
Table 4 Top 10 Journals and Co-Cited Journals by Papers of Exosome in CVD |
The purpose of co-citation analysis is to measure the degree of relationship between articles. According to Table 4, the most frequently co-cited journals were Circulation Research (5506 citations, TLS: 473,799), followed by Circulation (3104 citations, TLS: 318,897), PLOS ONE (2463 citations, TLS: 235,082). In the past decade, the impact factors of the top ten cited journals have shown an upward trend.
Figure 4 shows that China has the most influence among the 15 institutions, followed by the United States. Among the top six major institutions, Nanjing Medical University and Tongji University mainly focus on domestic research fields, while Utrecht University, Harvard University, Université Paris Cité, and Pennsylvania Commonwealth System of Higher Education are more involved in international cooperation.
When turning to the collaborations between institutions and journals, Theranostics is at the top of the list based on the density of the lines, followed by Frontiers in Cardiovascular Medicine, Journal of Cardiovascular Translational Research, Circulation Research, Cardiovascular Research, Frontiers in Cell and Development Biology.
References and Co-Cited References
We listed the top 10 frequently cited references related to research on exosomes in cardiovascular medicine in Table 5, including 8 original research and 2 reviews. The article with the highest citation (1583) is “Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury” written by Lai, Ruenn Chaiet al published in STEM CELL RESEARCH in 2010.37 The article titled “Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension” written by Lee, Changjin et al in 2012 published in CIRCULATION with the highest IF (37.8).38 All the articles came from different writers.
![]() |
Table 5 The Top 10 References and Co-Cited References Based on the Number of Citations |
Co-citation is when two or more papers are cited by one or more papers at the same time.39 All the co-cited references had over 150 citations, and the references listed top 3 were all cited over 250 times (Table 5). The article “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells” written by Hadi Valadi et al in 2007 ranks first,40 followed by the article “Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury” authored by Ruenn Chai Lai et al in 2010.37 All of the articles in the list were original research. There are currently no articles published after 2020 in the list.
Burst detection can be used for events that occur abnormally frequently or suddenly over a period of time.41 Significant changes in citations within a specific period of time were detected through co-citation burst detection. This is a method of discovering a decrease or increase in specific co-citation studies. Citation-based clustering analysis revealed different research hotspots of exosomes in cardiovascular diseases.
The graph spectrum of the highest cited references and the references with the strongest citation burst is shown in Figure 5 based on CiteSpace. In Figure 5A, the larger the node is, the higher the frequency of the document is. In fact, the higher the number of citations is. For a layer of different colors and thicknesses of a point, the color represents the time of publication. The closer it is to blue purple, the earlier it is quoted, and the closer it is to yellow, the more recent it is quoted. The thickness represents the number of citations in that time period (year), and the thicker it is, the more the number of citations. The top five references are “Ibrahim AGE (2014)”, “Khan M (2015)”, “Xiao J (2016)”, “Yu B (2015)” and “Gallet R (2017)”. An article published by Kalluri et al in SCIENCE in 2020 had the highest burst strength (44.66). The important information in Figure 5B reflects or prompts is: there are 13 clusters, showing the top 8 clusters. The top 7 clusters were “pregnancy” (cluster #0), “extracellular vesicles” (cluster #1), “cell-derived microparticles” (cluster #2), “myocardial infarction” (cluster #3), “nanomedicine” (cluster #4), “telocytes” (cluster #5), “laterality” (cluster #6) and “osteoarthritis” (cluster #7), Among these, 3 clusters, “extracellular vesicles” (cluster #1), “cell-derived microparticles” (cluster #2) and “myocardial infarction” (cluster #3) had the highest number of published papers in recent years. These fields to some extent indicate the research centers in the cross field of exosomes and cardiovascular.
![]() |
Figure 5 Analysis of Co-cited references. (A) the co-cited references network graph in WOSCC. (B) Keyword cluster map of co-cited references network. |
Figure 6 shows the top 25 references with the strongest citation burst. These references are distributed in a specific time period and can reflect the hotspots at that time. The first citation outbreak occurred between 2011 and 2015, and the latest citation outbreak references have been recorded since 2021. The largest explosive force came from Kalluri et al (Strength = 44.66), Théry et al (Strength = 41.84) and lbrahim et al (Strength = 40.23). In addition, Kalluri et al (2020), Huang et al (2020), and Mathieu et al (2019) have received more attention in recent years.
![]() |
Figure 6 Analysis of references. The top 25 references with the strongest citation bursts. The blue line represents the time from its first appearance to 2023; the redline represents the burst time. |
Keyword Analysis
Keyword is the essence of research topics. Table 6 lists the top 20 high-frequency keywords. The most common keywords were “exosome” (1242 times; TLS:10,257). A comprehensive analysis of keyword clustering was conducted using CiteSpace and VOSviewer software. The analysis results are shown in Figure 7A. The most frequently occurring keyword and highest centrality are “extracellular vesicles” (Fre = 570), followed by “exosome” (Fre = 440) and “myocardial infarction” (Fre = 316). Figure 7B reveals that the most significant cluster was “mechanisms” (#0), followed by “cardiovascular” (#1), “mesenchymal stem cells” (#2), “extracellular vesicles” (#3), “myocardial infarction” (#4), “endothelial cells” (#5), “cardiomyocyte apoptosis” (#6), “urine exosomes” (#7), “heart failure” (#8). Figure 7C shows the timeline analysis of the keyword cluster of exosomes in CVD based on CiteSpace software.
![]() |
Table 6 Top 20 Frequency Keywords Related to Exosome in CVDs |
By analyzing emerging keywords, we can find the significant occurrence of specific terms within a specific time interval. These valuable pieces of information provide insights into the sustained development of the research field and become important indicators for depicting the latest trends in academic pursuits. The top 25 keywords that exhibit the strongest citation bursts are presented in Figure 8. These keywords were distributed in a specific time period and can reflect the hot spots at that time. Over a decade, the longest outbreak period is proteomic analysis, which lasts from 2004 to 2017. In contrast, the highest burst intensities associated with exosomes in cardiovascular disease came from circulating microRNAs (intensity = 9.36), cardiac progenitor cells (intensity = 8.63), mediated transfer (intensity = 7.5) and membrane vesicles (intensity = 7.09). In addition, fibrosis (2015), as well as atrial fibrillation (2010) and inhibition (2013) were found to be the most concern at present.
![]() |
Figure 8 The top 25 keywords with the strongest citation bursts. The red segment of the blue line represents the burst references. (B) Cluster diagrams of references. |
Figure 9 shows the association and connection between the top 20 co-cited references, authors and keywords (only 19) in the application of exosomes in cardiovascular aspects, which are presented in the form of an alluvial flow diagram. Obviously, the top 20 most frequently co-cited references are more closely related to the study of exosomes, and the related fields of cardiovascular are also reflected.
![]() |
Figure 9 The relationship of the top 20 co-cited reference, author and keyword evolutions based on an alluvial flow map based on R for exosomes in CVDs. |
Discussion
General Information
The number of annual publications can reflect the development of a specific field.42 From 2020 to 2021, the number of publications increased from 231 to 344, with a rate of 70%. Citations increased from 8617 to 12952 which was an even more significant increase. This showed that researchers have realized the importance of exosomes and started to carry out extensive research on them. At the same time, these early studies have been widely recognized and cited. Between 2021 and 2022, the number of articles published in this research direction decreased to 285, but the number of citations increased to 13431. This shows that there may be some bottlenecks in the research of exosomes, or it is due to the global epidemic, but it is still a research hotspot. After 2022, publications and citations have declined significantly, which indicates that the research in this field may become mature, and may also be affected by external factors, such as the global epidemic, changes in the research environment, allocation of funds, changes in research direction, etc.
The results of the country analysis showed that China has far more documents than other countries, and citation ranks first. However, it can be clearly seen that China’s citation/document is not very leading. The Netherlands is in the leading position in citation/document. It can be seen that its papers are of high quality and are cited more. In terms of total connection strength, the United States is more advanced, which shows that the United States pays more attention to global cooperation. In addition, Italy, Britain, Germany, the Netherlands and other countries have also made significant contributions to the development of this field, and the publications of scholars from these countries can also be concerned. The institution analysis also indicated that Nanjing Medical University ranked first with 52 articles, Tongji University ranked second with 40 articles, and Shanghai Jiao Tong University ranked third with 36 articles. The overall article quality of Soochow University is high for citation ranks first. The top 10 institutions that have made great contributions to the development of exosomes in cardiovascular diseases are all in China. This may be due to the large population, high prevalence of cardiovascular disease and heavy treatment burden.43–46
The journal analysis results show that the journal with the highest number of publications is “International Journal of Molecular Sciences”, and each article of “Journal of Cellular and Molecular Medicine” has been cited 43.13 times on average, which is the highest number of citations among all journals, while “Circulation Research” has the highest total link strength, impact factors and H-index. These three journals are particularly important (especially Circulation Research), and they have high influence and links in the academic community. Therefore, when studying this field, it is recommended to pay more attention to the literature of these journals. Marban, Eduardo has the highest number of publications and the most citations. Marban, Eduardo and Barile, Lucio both hold the highest H-Index. Secondly, we can observe that Susmita Sahoo, the sixth-ranked author, has 129.33 citations/articles, which is the highest in the top ten. This shows that her research results have a high influence on the academic community. Their articles should be read through when studying the field. Barile, L and Lai Rc have a high number of co-citations for their articles, reflecting the research direction and the interdisciplinary development of academia. It is worth pointing out that cluster analysis shows that a large part of the published papers are from China. Academic research is both domestic and international cooperation. In order to make a breakthrough, cooperation at home and abroad is necessary.
Analysis of Key Literature
The hot research directions can be obtained by analyzing the contents of highly cited and highly cited literature. We listed the top 10 frequently cited references related to research on exosomes in cardiovascular medicine in Table 5, including 8 original research and 2 reviews. The article with the highest citation (1583) is “Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury” written by Lai, Ruenn Chai et al published in STEM CELL RESEARCH in 2010.37 It tells us that MSCs can secrete exosomes to mediate their cardioprotective paracrine effects, expanding the vision of cell-cell mediation of tissue injury and repair, and opening up ideas for the development of tissue repair biologics. The article titled “Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension” written by Lee, Changjin et al in 2012 published in CIRCULATION with the highest IF.38 This study confirms that MEX can pleiotropically protect the lung and inhibit pulmonary hypertension by inhibiting hyperproliferative pathways, including hypoxia-induced STAT3-mediated signaling. It proves that exosomes play a direct and crucial role in regulating pulmonary arterial hypertension and provides an essential basis for future research.
All the co-cited references had over 150 citations, and the references listed top 3 were all cited over 250 times (Table 5). The article “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells” written by Hadi Valadi et al in 2007 ranks first,40 followed by the article “Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury” authored by Ruenn Chai Lai et al in 2010.37 All of the articles in the list were original research. There are currently no articles published after 2020 in the list.
Burst detection can be used for events that occur abnormally frequently or suddenly over a period of time.41 Significant changes in citations within a specific period of time were detected through co-citation burst detection. This is a method of discovering a decrease or increase in specific co-citation studies. Citation-based clustering analysis revealed different research hotspots of exosomes in cardiovascular diseases.
The graph spectrum of the highest cited references and the references with the strongest citation burst is shown in Figure 5 based on CiteSpace. In Figure 5A, an article published by Kalluri et al in SCIENCE in 2020 had the highest burst strength. Figure 5B shows the clustering and time distribution of the citations. Among these, “extracellular vesicles”, “cell-derived microparticles” and “myocardial infarction” had the highest number of published papers in recent years. The above literature and the top-ranked highly cited and highly cited articles cover important research achievements of exosomes in cardiac regeneration, myocardial ischemia-reperfusion injury, myocardial hypertrophy and other aspects, and are published in different journals with high impact factors. They are widely cited in the field of exosome research and have an important impact on the research of cardiovascular disease and cell therapy.
Research Hotspots and Trends
Keyword is the essence of research topics. A comprehensive analysis of keyword clustering was conducted using CiteSpace and VOSviewer software. Table 6 lists the top 20 high-frequency keywords. The current hotspots and future trends in the study of exosomes in CVDs were searched by keyword frequency and total link strength. It is possible to realize the allocation and growth of distinct research hotspots in this field.
The most common keywords were “exosome”, followed by “extracellular vesicles” and “angiogenesis”. The analysis results are shown in Figure 6. Keyword clusters can be divided into two main areas, corresponding to different applications of exosomes in CVD. One group focuses on the use of exosomes as biomarkers, the detection and diagnosis of cardiovascular diseases, and how it achieves its goals. Another group focused on the mechanism and function of exosomes in cardiovascular disease, including “oxidative stress”, “heart failure”, etc.
By analyzing emerging keywords, we can reveal the significant occurrence of specific terms within a specific time interval. These valuable pieces of information provide insights into the sustained development of the research field and become important indicators for depicting the latest trends in academic pursuits. The top 25 keywords that exhibit the strongest citation bursts are presented in Figure 7. The top 25 keywords that exhibit the strongest citation bursts were presented. Over the span of a decade, “circulating microRNAs” ranked first with the highest burst strength followed by “cardiac progenitor cells” and “membrane-vesicles”. We can tell that from 2004 to 2018, the research hotspots mainly focus on what mechanisms and pathways extracellular vesicles affect cardiovascular disease. Thus, we see the citation bursts of such keywords as “mediated transfer”, “mechanism” and “pathway”. Then, the emerging keywords of “cardioprotection”, “cardiac regeneration”, “cancer” and “inhibition” suggest that the focus of the research has shifted to the specific role of extracellular vesicles in specific diseases. It is also worth noting that “fibrosis”, “atrial fibrillation” and “inhibition” have shown the most obvious outbreak in recent years, which indicates that they will continue to be hot topics for future research.
In Figure 8, based on the alluvial flow diagram or three field diagrams, the association and connection between the top 20 commonly cited references, authors, and keywords in exosomes in CVD are presented. The top 20 most commonly cited references were found to be more closely related to extracellular vesicle research and represent various types of CVD.
Mechanisms of Exosomes in CVDs
Exosomes are a type of extracellular vesicle (EVs). More and more evidence showed that EVs can transmit bioactive molecules to participate in cell-cell communication, so the research on EVs began to develop.47,48 With the continuous in-depth research on EVs, they can be roughly divided into three types [exosomes (30–100 nm), microparticles (0.1–1 µm), and apoptotic bodies (1–5 µm)] based on their size, biological mechanisms, and surface markers.49–51 Exosomes have the characteristics of carrying and transferring DNA, RNA, miRNA and protein as well as promoting cell-cell communication, which play an important role in vivo.52–54 Research has shown that exosomes carrying miRNA can mediate the protective effects of exercise on diabetic myocardial injury.55 In addition, exosome-mediated signal transduction is involved in the progress of cardiovascular diseases, such as myocardial infarction, myocardial ischemia and atherosclerosis.56–60
Exosomes Involved in Apoptosis in CVDs
Apoptosis is the autonomous and orderly death of cells controlled by genes.61 In CVDs, it is related to heart failure (HF),62,63 myocardial infarction (MI)64,65 and reperfusion injury,66,67 etc. It was found that there is a relationship between exosomes and myocardial cell apoptosis. Gupta et al found that the release of heat shock protein (HSP) 60 was associated with exosomes,68 which can bind selectively to the cardiac myocyte and induce apoptosis.69–71 Yu et al indicated that the Circ-cacng2/mir-197-3p/caspase3 axis is an important pathway for MM-exosomes to inhibit cardiomyocyte viability and promote apoptosis.72 Huang pointed out that exosome-mediated miR-328-3p transfer can promote myocardial cell apoptosis by activating Caspase-3 signaling.73
On the contrary, some authors have shown that miR-144, miR-126, etc. inhibited the process of cell apoptosis through exosomes.74–77 Wen et al found that exosomes derived from MSC are capable of inhibiting cell apoptosis damage under hypoxic conditions by delivering miR-144 to cells, which targets the PTEN/AKT pathway.78 Wang et al discovered that exosomes derived miR-126 cab attenuate apoptosis from ischemia and reperfusion injury by targeting ERRFI1.79 The above studies indicate that exosomes indirectly protect or promote cell apoptosis.
Exosomes Involved in Angiogenesis in CVDs
In recent years, attempts have been made to improve CVD by promoting angiogenesis since the limited blood supply is closely related to heart failure.80–83 Exosomes were found to promote angiogenesis. Sun et al found that HIF-1α Overexpressed exosomes rescued the abilities of HUVECs damaged by hypoxia, thereby promoting angiogenesis.59 Xiao indicated that MSC-exosomes are necessary for vascular endothelial cells (VECs) to induce angiogenic activity.84–86 Zhang et al revealed that Plasma exosomes play an angiogenic role in ECs through the FGFR2 signaling pathway under the regulation of CD44.87 Wang et al showed that ADSC-exosomes can repair MI-induced cardiac injury through the miRNA-205 signaling pathway, which indicates that DSC exosomes containing miRNA-205 have good prospects in MI.88
Exosomes Involved in Inflammation in CVDs
Low-degree chronic inflammation will increase the risk of atherosclerosis and insulin resistance, which is the main mechanism for the development of CVD.89–91 Exosomes also play an important role in it.92–94 Gao et al demonstrated that Mature dendritic cell (DC) - derived exosomes in membrane TNF-α mediated by NF-κB pathway increase endothelial inflammation and atherosclerosis.79 Tang et al indicated that the CDS region of PPARα mRNA directly binds to mir-27b-3p of exosomes to downregulate PPARα, thus leading to inflammation and atherosclerosis.95
By contrast, more research pointed to the alleviating effect of exosomes on inflammation. Laura et al showed that exosomes produced by naive bone marrow-derived macrophages (BMDM-exosome) contain anti-inflammatory microRNA-99a/146b/378a, suppressing inflammation by targeting NF-κB and TNF-α signaling.96 Yao found that high-level expression of MiR-25-3p in P-exosomes can reduce ADAM10 expression to inhibit ox LDL-induced inflammation and lipid deposition.97 The above research demonstrates the impact of exosomes on inflammation. Most of the focus is on NF-κB pathway. Inflammation in CVDs is closely related to atherosclerosis, pending further research on the treatment of atherosclerosis in the direction of exosomes.
Therapeutic Role of Exosomes in CVDs
The basic function of exosomes is to deliver cargo intracellularly, which can be used as an attractive drug delivery agent.98–100 At the same time, stem cell-derived exosomes have cardioprotective effects and have great prospects in the treatment of CVD.101–103 Most importantly, exosomes derived from microRNAs (miRNAs) are important biomarkers in cardiovascular diseases, and they are expected to be put into clinical risk assessment after further research.104–106
Exosomes as a Potential Biomarker in CVDs
Some studies have shown that exosomes can be used as an important biomarker in cardiovascular disease.105,106 Exosomes have different sources and quantities under different pathological conditions, and have great potential for disease-specific biomarkers.107,108 Silvia-Palacios reported that Ischemia promotes an increase in exosome release in patients with myocardial infarction. After acute MI and reperfusion, a high content of mir-223-3p (a miRNA targeting inflammatory molecules) was found in patients’ exosomes.109 In adipose tissue (AT), Xie et al found that exosomes released from adipose tissue at different locations and under stress have different atherosclerosis-promoting effects.110 In patients with heart failure, elevated levels of miR-217 in cardiac tissue are associated with poorer left ventricular ejection fraction.111,112 Allison et al listed exosomal miRNAs of specific interest in CVD, highlighting the exosomal miRNAs with high clinical relevance, including MiR-19b (significantly increased in patients with unstable angina),113 MiR-130a (overexpression leads to atherosclerosis),114 MiR-10b (elevated levels are seen in patients with atherosclerotic plaques, but have myocardial protection against apoptosis in hypoxic environments),115,116 MiR-33 (increased collagen deposition in myocardial infarction and promotes cardiac fibrosis through the p38 MAPK signaling pathway),117 MiR-186-5p (levels decreased within 72 hours of the onset of acute myocardial infarction).118,119 Ji et al indicated recently that foam cell-derived exosomes can be used as circulating biomarkers for detecting atherosclerosis in vitro after fluorescence labeling.120
Exosomes as Therapeutic Agents in CVDs
Researchers have found that exosomes not only play an important role in the prognosis and diagnosis of CVD, but can also be used for treatment.121–123 Research has found that exosomes can regulate oxidative stress (OS) in CADs, and miRNAs play an important role in this process.123–125 It can reduce OS-induced cell apoptosis by regulating OS. Arslan et al indicated that a single intravenous injection of extracellular vesicles (5mm) before reperfusion can reduce the infarct area of mice by about 45%.126 Exosomes from various cell sources have potential therapeutic effects on CVD. Exosomes derived from hematopoietic stem cells (HSCs) provide support for repairing heart tissue by differentiating into cardiomyocytes.127,128 Exosomes derived from cardiospheres (CDCs) seem to be able to convert inert dermal fibroblasts into cells with therapeutic activity, which may reduce scar size and improve cardiac function in chronic myocardial infarction models.129 Exosomes derived from mesenchymal stem cells (MSCs) help reduce the infarct size of mouse heart tissue.37 Multiple methods were developed to enhance exosome activities,130,131 but its long-lasting efficacy and safety remain to be studied. The potential impact of targeted modifications on the structural integrity of exosomes remains uncertain.132 The current research focuses on optimizing the route of dosing,133 preparing formulations with excellent in vivo stability,134 improving target specificity,135,136 and designing exosomes without changing their biophysical and biochemical properties.
Exosomes can transport and deliver proteins and nucleic acids intracellularly, which contributes to their potential as drug delivery agents for CVD.137 Cardiomyocyte-specific peptides exist on the surface of exosomes isolated from CDCs expressing lamb 2B and can lead to increased uptake by cardiomyocytes.138 Mir-199b-5p exists in exosomes isolated from HIPSC ECs and promotes angiogenesis.139 Exosomes have the high efficiency and specificity of targeted delivery of cargo, and will not cause immune response. They have the prospect of being used as natural drug delivery vehicles, which is worthy of further exploration and is expected to be applied in clinics. As a drug delivery vehicle, its current defect is that there is no standardized large-scale method to produce exosomes, and its loading capacity and targeting ability need to be enhanced at the same time.133,140
Limitation
This study has some limitations. First, because our research was limited to the scientific web, we did not search other academic databases and may have missed some influential articles. However, due to the limitation of bibliometric software, it is difficult to combine and analyze various databases. Secondly, only articles published in English enter the scope of this study. Therefore, relevant studies in other languages were not included. However, because English is widely used in academia, we believe that the most important studies have been included in our analysis. Third, this study includes articles and reviews, and there may be a certain bias in using the number of citations to reflect the academic impact of articles. Fourthly, although a variety of commonly used software is used for bibliometric analysis, there are differences and biases in the operation mode and analysis results of different software. Therefore, the results of different software were summarized to improve the reliability of this paper.
Conclusion
In conclusion, the number of annual publications on the use of exosomes in CVDs has continued to rise basically over the past decade except for the possible impact of the epidemic. China, as a pioneer country in the field, has contributed to the development of exosomes in CVDs greatly. Among the institutions, Nanjing Med University ranks first in the number of publications, citations, and total link strength. By analyzing journals found that International Journal of Molecular Sciences has the highest number of publications while Circulation Research had the highest number of citations, indicating their importance in the field. The author analysis identified Marban Eduardo had the highest number of published papers. The most frequently co-cited authors were Barile, L. While focusing on basic research, the most common keywords were “exosome”. Current research on exosomes in CVDs focuses on exosomes, extracellular vesicles and angiogenesis. These will be hot topics for future research. This study comprehensively introduces the research status of cardiovascular disease exosomes by analyzing and summarizing cutting-edge and popular directions by drawing visual graphics. It provides a foundation and new frontiers for future research on exosomes in CVD, enabling readers to obtain useful information quickly and effectively in this field (Figure 10). These findings are expected to help scholars grasp the research direction, further study exosomes in cardiovascular disease, and lay a theoretical foundation for the clinical application of cardiovascular disease in the future.
Data Sharing Statement
The data in this study is accessible in the public domain and not of a confidential nature.
Acknowledgments
The authors want to thank CiteSpace and VOSviewer for free access by researchers.
Author Contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Funding
This work was supported by grants from the National Natural Science Foundation of China (82174120, 82204831), Natural Science Foundation of Shanghai (No. 21ZR1463100), Program of Shanghai Academic Research Leader (22XD1423400), Shanghai Sailing Program (No. 22YF1448800) and, the China Postdoctoral Science Foundation (No. 2021M692153).
Disclosure
The authors declare that they have no competing interest in this work.
References
1. He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. In: Theranostics. Ivyspring International Publisher; 2018. doi10.7150/thno.21945
2. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/SCIENCE.AAU6977
3. Frühbeis C, Fröhlich D, Kuo WP, et al. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biology. 2013;11(7). doi:10.1371/journal.pbio.1001604
4. Pegtel DM, Gould SJ. Exosomes. Annual Review of Biochemistry. 2019;88:487–514. doi:10.1146/ANNUREV-BIOCHEM-013118-111902
5. Tlaposo G, Nijman HW, Leijendekker R, Hardingfl Cornelis C, Melief JM, Geuze HJ. B lymphocytes secrete antigen-presentingVesicles. J Exp Med. 1996;183(3):1161–1172. doi:10.1084/jem.183.3.1161
6. Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14:195–208. doi:10.1038/nri3622
7. Théry C, Regnault A, Garin J, et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol. 1999;147(3):599–610. doi:10.1083/JCB.147.3.599
8. Korkut C, Ataman B, Ramachandran P, et al. Trans-Synaptic Transmission of Vesicular Wnt Signals through Evi/Wntless. Cell. 2009;139(2):393–404. doi:10.1016/j.cell.2009.07.051
9. Verweij FJ, Revenu C, Arras G, et al. Live Tracking of Inter-organ Communication by Endogenous Exosomes In Vivo. Developmental Cell. 2019;48(4):573–589.e4. doi:10.1016/J.DEVCEL.2019.01.004
10. Yuan Y, Mei Z, Qu Z, et al. Exosomes secreted from cardiomyocytes suppress the sensitivity of tumor ferroptosis in ischemic heart failure. Signal Transduction and Targeted Therapy. 2023;8(1). doi:10.1038/S41392-023-01336-4
11. Machtinger R, Laurent LC, Baccarelli AA. Extracellular vesicles: roles in gamete maturation, fertilization and embryo implantation. Human Reproduction Update. 2016;22(2):182–193. doi:10.1093/HUMUPD/DMV055
12. Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genom Prot Bio. 2015;13(1):17–24. doi:10.1016/J.GPB.2015.02.001
13. Ghafarian F, Pashirzad M, Khazaei M, et al. The clinical impact of exosomes in cardiovascular disorders: from basic science to clinical application. J Cell Physiol. 2019;234(8):12226–12236. doi:10.1002/JCP.27964
14. Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–1232. doi:10.1016/J.CELL.2016.01.043
15. Isola AL, Chen S. Exosomes: the messengers of health and disease. Curr Neuropharmacol. 2017;15(1):157. doi:10.2174/1570159X14666160825160421
16. Bei Y, Chen T, Banciu DD, Cretoiu D, Xiao J. Circulating exosomes in cardiovascular diseases. Adv Exp Med Biol. 2017;998:255–269. doi:10.1007/978-981-10-4397-0_17
17. Lai Z, Liang J, Zhang J, et al. Exosomes as a delivery tool of exercise-induced beneficial factors for the prevention and treatment of cardiovascular disease: a systematic review and meta-analysis. Front Physiol. 2023;14. doi:10.3389/FPHYS.2023.1190095
18. Zhao W, Zheng XL, Zhao SP. Exosome and its roles in cardiovascular diseases. Heart Failure Rev. 2015;20(3):337–348. doi:10.1007/S10741-014-9469-0
19. Malik ZA, Kott KS, Poe AJ, et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circul Physiol. 2013;304(7). doi:10.1152/AJPHEART.00835.2012
20. Zhang TR, Huang WQ. Angiogenic exosome-derived microRNAs: emerging roles in cardiovascular disease. J Cardiovasc Translat Res. 2021;14(5):824–840. doi:10.1007/S12265-020-10082-9
21. Wang X, Chen Y, Zhao Z, et al. Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction. J Am Heart Assoc. 2018;7(15). doi:10.1161/JAHA.118.008737
22. Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006;20(6):661–669. doi:10.1096/FJ.05-5211COM
23. Crisostomo PR, Abarbanell AM, Wang M, Lahm T, Wang Y, Meldrum DR. Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. Am J Physiol Heart Circul Physiol. 2008;295(4):H1726–H1735. doi:10.1152/AJPHEART.00236.2008
24. Chimenti I, Smith RR, Li TS, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circul Res. 2010;106(5):971–980. doi:10.1161/CIRCRESAHA.109.210682
25. Feng Y, Huang W, Wani M, Yu X, Ashraf M. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One. 2014;
26. Ibrahim AGE, Cheng K, Marbán E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports. 2014;2(5):606–619. doi:10.1016/J.STEMCR.2014.04.006
27. Ninkov A, Frank JR, Maggio LA. Bibliometrics: methods for studying academic publishing. Perspect Med Educat. 2022;11(3):173–176. doi:10.1007/S40037-021-00695-4
28. Diane Cooper I. Bibliometrics basics. J Med Lib Assoc. 2015;103(4):217–218. doi:10.3163/1536-5050.103.4.013
29. van Eck NJ, Waltman L. Software survey: vOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–538. doi:10.1007/S11192-009-0146-3
30. Chen C. CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. Journal of the American Society for Information Science and Technology. 2006;57(3):359–377. doi:10.1002/ASI.20317
31. Schuemie MJ, Talmon JL, Moorman PW, Kors JA. Mapping the domain of medical informatics. Methods of Information in Medicine. 2009;48(1):76–83. doi:10.3414/ME0576
32. Donnelly JP. A systematic review of concept mapping dissertations. Evaluation and Program Planning. 2017;60:186–193. doi:10.1016/J.EVALPROGPLAN.2016.08.010
33. Barile L, Moccetti T, Marbán E, Vassalli G. Roles of exosomes in cardioprotection. Eur Heart J. 2017;38(18):1372–1379. doi:10.1093/EURHEARTJ/EHW304
34. Lefer DJ, Marbán E. Is cardioprotection dead? Circulation. 2017;136(1):98–109. doi:10.1161/CIRCULATIONAHA.116.027039
35. Bobis-Wozowicz S, Marbán E. Editorial: extracellular vesicles as next generation therapeutics. Front Cell Develop Biol. 2022;10. doi:10.3389/FCELL.2022.919426
36. Davidson SM, Boulanger CM, Aikawa E, et al. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles. Cardiovasc Res. 2023;119(1):45–63. doi:10.1093/CVR/CVAC031
37. Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research. 2010;4(3):214–222. doi:10.1016/J.SCR.2009.12.003
38. Lee C, Mitsialis SA, Aslam M, et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012;126(22):2601–2611. doi:10.1161/CIRCULATIONAHA.112.114173
39. Small H. Co-citation in the scientific literature: a new measure of the relationship between two documents. Journal of the American Society for Information Science. 1973;24(4):265–269. doi:10.1002/ASI.4630240406
40. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. doi:10.1038/NCB1596
41. Ye R, Cheng Y, Ge Y, Xu G, Tu W. A bibliometric analysis of the global trends and hotspots for the ketogenic diet based on CiteSpace. Medicine. 2023;102(5):E32794. doi:10.1097/MD.0000000000032794
42. Peng C, He M, Cutrona SL, Kiefe CI, Liu F, Wang Z. Theme trends and knowledge structure on mobile health apps: bibliometric analysis. JMIR mHealth and uHealth. 2020;8(7):e18212. doi:10.2196/18212
43. Xie F, Shu Q, Li J, Chen Z. An exploration of status of chronic diseases and its influencing factors of older people in Chinese home care and long-term care facilities: a cross-sectional study. Frontiers in Public Health. 2023;11. doi:10.3389/FPUBH.2023.1321681
44. He D, Qin K, Li J, et al. Increased incidence risks of cardiovascular disease among cancer patients: evidence from a population-based cohort study in China. International Journal of Cardiology. 2024;396:131362. doi:10.1016/J.IJCARD.2023.131362
45. Lu W, Yuan J, Liu Z, et al. Worldwide trends in mortality for hypertensive heart disease from 1990 to 2019 with projection to 2034: data from the global burden of disease 2019 study. European Journal of Preventive Cardiology. 2024;31(1):23–37. doi:10.1093/EURJPC/ZWAD262
46. Gao Q, Li L, Bai J, et al. Association of stage 1 hypertension defined by the 2017 ACC/AHA guideline with cardiovascular events and mortality in Chinese adults. Chinese Medical Journal. 2024;137(1). doi:10.1097/CM9.0000000000002669
47. Yáñez-Mó M, Siljander PRM, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4(2015):1–60. doi:10.3402/JEV.V4.27066
48. Zhou X, Xie F, Wang L, et al. The function and clinical application of extracellular vesicles in innate immune regulation. Cellular & Molecular Immunology. 2020;17(4):323–334. doi:10.1038/S41423-020-0391-1
49. Fu S, Zhang Y, Li Y, Luo L, Zhao Y, Yao Y. Extracellular vesicles in cardiovascular diseases. Cell Death Discovery. 2020;6(1). doi:10.1038/S41420-020-00305-Y
50. Jadli AS, Ballasy N, Edalat P, Patel VB. Inside(sight) of tiny communicator: exosome biogenesis, secretion, and uptake. Mol Cell Biochem. 2020;467(1–2):77–94. doi:10.1007/S11010-020-03703-Z
51. Chong SY, Lee CK, Huang C, et al. Extracellular vesicles in cardiovascular diseases: alternative biomarker sources, therapeutic agents, and drug delivery carriers. Int J Mol Sci. 2019;20(13):3272. doi:10.3390/IJMS20133272
52. Krämer-Albers EM, Hill AF. Extracellular vesicles: interneural shuttles of complex messages. Curr Opin Neurobiol. 2016;39:101–107. doi:10.1016/J.CONB.2016.04.016
53. Harding CV, Heuser JE, Stahl PD. Exosomes: looking back three decades and into the future. J Cell Biol. 2013;200(4):367–371. doi:10.1083/JCB.201212113
54. Ludwig AK, Giebel B. Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol. 2012;44(1):11–15. doi:10.1016/J.BIOCEL.2011.10.005
55. Chaturvedi P, Kalani A, Medina I, Familtseva A, Tyagi SC. Cardiosome mediated regulation of MMP9 in diabetic heart: role of mir29b and mir455 in exercise. J Cell & Mol Med. 2015;19(9):2153–2161. doi:10.1111/JCMM.12589
56. Wang C, Li Z, Liu Y, Yuan L. Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets. Theranostics. 2021;11(8):3996–4010. doi:10.7150/THNO.56035
57. Zhao J, Li X, Hu J, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovas Res. 2019;115(7):1205–1216. doi:10.1093/CVR/CVZ040
58. Sharma S, Sharma U. Exosomes in cardiovascular diseases: a blessing or a sin for the mankind. Mol Cell Biochem. 2022;477:833–847. doi:10.1007/s11010-021-04328-6
59. Sun J, Shen H, Shao L, et al. HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis. Stem Cell Research & Therapy. 2020;11(1). doi:10.1186/S13287-020-01881-7
60. He N, Zhang Y, Zhang S, Wang D, Ye H. Exosomes: cell-free therapy for cardiovascular diseases. J Cardiov Translat Res Spring. 2020;13:713–721. doi:10.1007/s12265-020-09966-7
61. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239–257. doi:10.1038/BJC.1972.33
62. Al-Masri A. Apoptosis and long non-coding RNAs: focus on their roles in heart diseases. Pathology, Research and Practice. 2023;251. doi:10.1016/J.PRP.2023.154889
63. Sabbah HN, Sharov VG. Apoptosis in heart failure. Progress in Cardiovascular Diseases. 1998;40(6):549–562. doi:10.1016/S0033-0620(98)80003-0
64. Krijnen PAJ, Nijmeijer R, Meijer CJLM, Visser CA, Hack CE, Niessen HWM. Apoptosis in myocardial ischaemia and infarction. J Clin Pathol. 2002;55(11):801–811. doi:10.1136/JCP.55.11.801
65. Frangogiannis NG. Pathophysiology of myocardial infarction. Comprehensive Physiology. 2015;5(4):1841–1875. doi:10.1002/CPHY.C150006
66. Zhu X, Li S, Huang C, Huang G, Xu J. LncRNA CRNDE inhibits cardiomyocytes apoptosis by YAP1 in myocardial ischaemia/reperfusion injury. Autoimmunity. 2021;54(4):204–212. doi:10.1080/08916934.2021.1913580
67. Liao S, Luo Y, Chunchai T, et al. An apoptosis inhibitor suppresses microglial and astrocytic activation after cardiac ischemia/reperfusion injury. Inflamm Res. 2022;71(7–8):861–872. doi:10.1007/S00011-022-01590-2
68. Gupta S, Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circul Physiol. 2007;292(6):H3052–H3056. doi:10.1152/AJPHEART.01355.2006
69. Li Y, Si R, Feng Y, et al. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. J Biol Chem. 2011;286(36):31308–31319. doi:10.1074/JBC.M111.246124
70. Yang Y, Huang C, Hui L, et al. Cathelicidins Target HSP60 To Restrict CVB3 transmission via disrupting the exosome and reducing cardiomyocyte apoptosis. Journal of Virology. 2023;97(3). doi:10.1128/jvi.01433-22
71. Kim SC, Stice JP, Chen L, et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circul Res. 2009;105(12):1186–1195. doi:10.1161/CIRCRESAHA.109.209643
72. Yu M, Ji L, Li S, et al. Exosomal circ-CACNG2 promotes cardiomyocyte apoptosis in multiple myeloma via modulating miR-197-3p/caspase3 axis. Exp Cell Res. 2022;417(2):113229. doi:10.1016/J.YEXCR.2022.113229
73. Huang J, Wang F, Sun X, et al. Myocardial infarction cardiomyocytes-derived exosomal miR-328-3p promote apoptosis via Caspase signaling. Am J Transl Res. 2021;13(4):2365–2378.
74. Luo Q, Guo D, Liu G, Chen G, Hang M, Jin M. Exosomes from MiR-126-Overexpressing adscs are therapeutic in relieving acute myocardial ischaemic Injury. Cell Physiol Biochem. 2017;44(6):2105–2116. doi:10.1159/000485949
75. Huang JH, Xu Y, Yin XM, Lin FY. Exosomes Derived from miR-126-modified MSCs promote angiogenesis and neurogenesis and attenuate apoptosis after spinal cord injury in rats. Neuroscience. 2020;424:133–145. doi:10.1016/J.NEUROSCIENCE.2019.10.043
76. Qu Q, Liu L, Cui Y, et al. miR-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure. Stem Cell Research & Therapy. 2022;13(1). doi:10.1186/S13287-022-03056-Y
77. Jiang M, Jike Y, Liu K, et al. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Molecular Cancer. 2023;22(1). doi:10.1186/S12943-023-01804-Z
78. Wen Z, Mai Z, Zhu X, et al. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020;11(1). doi:10.1186/s13287-020-1563-8
79. Wang W, Zheng Y, Wang M, Yan M, Jiang J, Li Z. Exosomes derived miR-126 attenuates oxidative stress and apoptosis from ischemia and reperfusion injury by targeting ERRFI1. Gene. 2019;690:75–80. doi:10.1016/J.GENE.2018.12.044
80. Jia S, Yao Y, Song Y, et al. Two-year outcomes after left main coronary artery percutaneous coronary intervention in patients presenting with acute coronary syndrome. J Inter Cardiol. 2020;2020. doi:10.1155/2020/6980324
81. Moriya J, Minamino T, Roser M. Angiogenesis, cancer, and vascular aging. Front Cardiovasc Med. 2017;4:4. doi:10.3389/FCVM.2017.00065
82. Liu Y, Yu X, Zhang W, Zhang X, Wang M, Ji F. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus. J Autoimmun. 2022;132. doi:10.1016/J.JAUT.2022.102863
83. Guo R, Li L, Su J, et al. Pharmacological activity and mechanism of tanshinone IIA in related diseases. Drug Design, Development and Therapy. 2020;14:4735–4748. doi:10.2147/DDDT.S266911
84. Kang K, Ma R, Cai W, et al. Exosomes secreted from CXCR4 overexpressing mesenchymal stem cells promote cardioprotection via akt signaling pathway following myocardial infarction. Stem Cells Internat. 2015;2015:1–14. doi:10.1155/2015/659890
85. Teng X, Chen L, Chen W, Yang J, Yang Z, Shen Z. Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation. Cell Physiol Biochem. 2015;37(6):2415–2424. doi:10.1159/000438594
86. Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Molec Med. 2014;92(4):387–397. doi:10.1007/S00109-013-1110-5
87. Zhang Q, Chen L, Huang L, et al. CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction. Molecular Medicine (Cambridge, Mass.). 2022;28(1):145. doi:10.1186/s10020-022-00575-5
88. Wang T, Li T, Niu X, et al. ADSC-derived exosomes attenuate myocardial infarction injury by promoting miR-205-mediated cardiac angiogenesis. Biology Direct. 2023;18(1). doi:10.1186/s13062-023-00361-1
89. Soysal P, Arik F, Smith L, Jackson SE, Isik AT. Inflammation, frailty and cardiovascular disease. Advances in Experimental Medicine and Biology. 2020;1216:55–64. doi:10.1007/978-3-030-33330-0_7/COVER
90. Shaito A, Aramouni K, Assaf R, et al. Oxidative Stress-induced endothelial dysfunction in cardiovascular diseases. Front Bio. 2022;27(3). doi:10.31083/J.FBL2703105
91. Frostegård J. Immunity, atherosclerosis and cardiovascular disease. BMC Medicine. 2013;11(1). doi:10.1186/1741-7015-11-117
92. Chan BD, Wong WY, Lee MML, et al. Exosomes in Inflammation and Inflammatory Disease. Proteomics. 2019;19(8). doi:10.1002/PMIC.201800149
93. Console L, Scalise M, Indiveri C. Exosomes in inflammation and role as biomarkers. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2019;488:165–171. doi:10.1016/J.CCA.2018.11.009
94. Liu J, Wu J, Li L, Li T, Wang J. The role of exosomal non-coding RNAs in coronary artery disease. Front Pharmacol. 2020;11. doi:10.3389/FPHAR.2020.603104
95. Tang Y, Yang LJ, Liu H, et al. Exosomal miR-27b-3p secreted by visceral adipocytes contributes to endothelial inflammation and atherogenesis. Cell Reports. 2023;42(1):111948. doi:10.1016/J.CELREP.2022.111948
96. Bouchareychas L, Duong P, Covarrubias S, Carpenter S, Van Keuren-Jensen K, Correspondence RLR. Macrophage exosomes resolve atherosclerosis by regulating hematopoiesis and inflammation via MicroRNA Cargo. Cell Reports. 2020;32:107881. doi:10.1016/j.celrep.2020.107881
97. Yao Y, Sun W, Sun Q, et al. Platelet-derived exosomal MicroRNA-25-3p inhibits coronary vascular endothelial cell inflammation through Adam10 via the NF-κB signaling pathway in apoe-/- mice. Frontiers in Immunology. 2019;10. doi:10.3389/FIMMU.2019.02205
98. Familtseva A, Jeremic N, Tyagi SC. Exosomes: cell-created drug delivery systems. Mol Cell Biochem. 2019;459(1–2. doi:10.1007/S11010-019-03545-4
99. Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015;219:396–405. doi:10.1016/J.JCONREL.2015.07.030
100. Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183–3195. doi:10.7150/THNO.52570
101. Davidson SM, Takov K, Yellon DM. Exosomes and Cardiovascular Protection. Cardiovascular Drugs and Therapy. 2017;31(1):77–86. doi:10.1007/S10557-016-6698-6
102. Zheng H, Liang X, Han Q, et al. Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence. Journal of Nanobiotechnology. 2021;19(1). doi:10.1186/S12951-021-01077-Y
103. Zeng CY, Xu J, Liu X, Lu YQ. Cardioprotective roles of endothelial progenitor cell-derived exosomes. Front Cardiovasc Med. 2021;8. doi:10.3389/FCVM.2021.717536
104. Jayaraman S, Gnanasampanthapandian D, Rajasingh J, Palaniyandi K. Stem cell-derived exosomes potential therapeutic roles in cardiovascular diseases. Front Cardiovasc Med. 2021;8. doi:10.3389/FCVM.2021.723236
105. Sinha PK, Sinha ES, Kaur J. Biomarkers of cardiac health and disease. Crit Rev Biomed Engine. 2019;47(5):395–407. doi:10.1615/CRITREVBIOMEDENG.2019031097
106. Koosha F, Alimohammadi N, Rafeian-Kopaei M. The exosomes: staring biomarkers and novel therapeutic strategies. Current Pharmaceutical Design. 2021;27(35):3714–3721. doi:10.2174/1381612827666210614102340
107. Kuwabara Y, Ono K, Horie T, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circulation. Cardiovascular Genetics. 2011;4(4):446–454. doi:10.1161/CIRCGENETICS.110.958975
108. Kanno S, Sakamoto T, Fukuta M, Kato H, Aoki Y. Stability of exosomes in the postmortem serum and preliminary study on exosomal miRNA expression profiling in serum from myocardial infarction cadavers. Internat J Legal Med. 2023;137(3):825–834. doi:10.1007/S00414-022-02913-Y
109. Silva-Palacios A, Arroyo-Campuzano M, Flores-García M, et al. Citicoline modifies the expression of specific miRNAs related to cardioprotection in patients with ST-segment elevation myocardial infarction subjected to coronary angioplasty. Pharmaceuticals. 2022;15(8). doi:10.3390/PH15080925
110. Xie Z, Wang X, Liu X, et al. Adipose-derived exosomes exert proatherogenic effects by regulating macrophage foam cell formation and polarization. J Am Heart Assoc. 2018;7(5). doi:10.1161/JAHA.117.007442
111. Nie X, Fan J, Li H, et al. miR-217 Promotes Cardiac Hypertrophy and Dysfunction by Targeting PTEN. Molecular Therapy. Nucleic Acids. 2018;12:254–266. doi:10.1016/J.OMTN.2018.05.013
112. Li H, Fan J, Yin Z, Wang F, Chen C, Wang DW. Identification of cardiac-related circulating microRNA profile in human chronic heart failure. Oncotarget. 2016;7(1):33–45. doi:10.18632/ONCOTARGET.6631
113. Li S, Geng Q, Chen H, et al. The potential inhibitory effects of miR-19b on vulnerable plaque formation via the suppression of STAT3 transcriptional activity. IntJ Mol Med. 2018;41(2):859–867. doi:10.3892/IJMM.2017.3263
114. Liu F, Liu Y, Du Y, Li Y. MiRNA-130a promotes inflammation to accelerate atherosclerosis via the regulation of proliferator-activated receptor γ (PPARγ) expression. Anatolian Journal of Cardiology. 2021;25(9):630–637. doi:10.5152/ANATOLJCARDIOL.2021.56721
115. Bidzhekov K, Gan L, Denecke B, et al. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost. 2012;107(4):619–625. doi:10.1160/TH11-09-0607
116. Wu L, Chen Y, Chen Y, et al. Effect of HIF-1α/miR-10b-5p/PTEN on Hypoxia-Induced Cardiomyocyte Apoptosis. J Am Heart Assoc. 2019;8(18). doi:10.1161/JAHA.119.011948
117. Chen Z, Ding HS, Guo X, et al. MiR-33 promotes myocardial fibrosis by inhibiting MMP16 and stimulating p38 MAPK signaling. Oncotarget. 2018;9(31):22047–22057. doi:10.18632/ONCOTARGET.25173
118. Ding J, Li H, Liu W, et al. miR-186-5p dysregulation in serum exosomes from patients with AMI aggravates atherosclerosis via targeting LOX-1. International Journal of Nanomedicine. 2022;17:6301–6316. doi:10.2147/IJN.S383904
119. Reiss AB, Ahmed S, Johnson M, Saeedullah U, De Leon J. Exosomes in cardiovascular disease: from mechanism to therapeutic target. Metabolites. 2023. doi:10.3390/metabo13040479
120. Ji M, Wei Y, Ye Z, et al. In vivo fluorescent labeling of foam cell-derived extracellular vesicles as circulating biomarkers for in vitro detection of atherosclerosis. Journal of the American Chemical Society. 2024. doi:10.1021/JACS.4C01173
121. Suzuki E, Fujita D, Takahashi M, Oba S, Nishimatsu H. Stem cell-derived exosomes as a therapeutic tool for cardiovascular disease. World J Stem Cells. 2016;8(9):297–305. doi:10.4252/WJSC.V8.I9.297
122. Chen X, Luo Q. Potential clinical applications of exosomes in the diagnosis, treatment, and prognosis of cardiovascular diseases: a narrative review. Annals of Translational Medicine. 2022;10(6):372. doi:10.21037/ATM-22-619
123. Cui M, Han Y, Yang J, Li G, Yang C. A narrative review of the research status of exosomes in cardiovascular disease. Annals of Palliative Medicine. 2022;11(1):363–377. doi:10.21037/APM-21-3364
124. Liu Y, Wang M, Liang Y, Wang C, Naruse K, Takahashi K. Treatment of oxidative stress with exosomes in myocardial ischemia. Int J Mol Sci. 2021;22(4):1–18. doi:10.3390/IJMS22041729
125. Zhang W, Liu R, Chen Y, Wang M, Du J. Crosstalk between oxidative stress and exosomes. Oxidat Med Cell Long. 2022;2022. doi:10.1155/2022/3553617
126. Arslan F, Lai RC, Smeets MB, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Research. 2013;10(3):301–312. doi:10.1016/J.SCR.2013.01.002
127. Lemcke H, Voronina N, Steinhoff G, David R. Recent progress in stem cell modification for cardiac regeneration. Stem Cells Internat. 2018;2018:1–22. doi:10.1155/2018/1909346
128. Burt R, Pearce W, Luo K, et al. Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease. Bone Marrow Transplantation. 2003;32(1):S29–S31. doi:10.1038/SJ.BMT.1704177
129. Tseliou E, Fouad J, Reich H, et al. Fibroblasts rendered antifibrotic, antiapoptotic, and angiogenic by priming with cardiosphere-derived extracellular membrane vesicles. J Am Coll Cardiol. 2015;66(6):599–611. doi:10.1016/J.JACC.2015.05.068
130. Zheng J, Chen P, Zhong J, et al. HIF-1α in myocardial ischemia-reperfusion injury (Review). Molecular Medicine Reports. 2021;23(5). doi:10.3892/MMR.2021.11991
131. Nocera AL, Mueller SK, Stephan JR, et al. Exosome swarms eliminate airway pathogens and provide passive epithelial immunoprotection through nitric oxide. J All Clin Immunol. 2019;143(4):1525–1535.e1. doi:10.1016/J.JACI.2018.08.046
132. Yin W, Ma H, Qu Y, et al. Targeted exosome-based nanoplatform for new-generation therapeutic strategies. Biomedical Materials (Bristol. 2024;19(3). doi:10.1088/1748-605X/AD3310
133. Pang J-L, Shao H, Xu X-G, et al. Targeted drug delivery of engineered mesenchymal stem/stromal-cell-derived exosomes in cardiovascular disease: recent trends and future perspectives. Front Bioeng Biotechnol. 2024;12. doi:10.3389/FBIOE.2024.1363742
134. Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024. doi:10.1038/S12276-024-01201-6
135. Rezaie J, Feghhi M, Etemadi T. A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Communication and Signaling: CCS. 2022;
136. Salunkhe S, Dheeraj B, Chitkara M, Mittal A, Mittal A. Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: strategies and significance. J Control Release. 2020;326:599–614. doi:10.1016/J.JCONREL.2020.07.042
137. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnol. 2011;29(4):341–345. doi:10.1038/NBT.1807
138. Mentkowski KI, Lang JK. Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo. Scientific Reports. 2019;9(1). doi:10.1038/S41598-019-46407-1
139. Ye M, Ni Q, Qi H, et al. Exosomes derived from human induced pluripotent stem cells-endothelia cells promotes postnatal angiogenesis in mice bearing ischemic limbs. Int J Bio Sci. 2019;15(1):158–168. doi:10.7150/IJBS.28392
140. Kumar MA, Baba SK, Sadida HQ, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduction and Targeted Therapy. 2024;9:1–41. doi:10.1038/s41392-024-01735-1
© 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.